Substitutes for Linahenz M OD 1000mg/5mg Tablet ER
Composition: Linagliptin 5mg + Metformin 1000mg
Linahenz M OD 1000mg/5mg Tablet ER is out of stock right now
Good news — 7 medicines with the same composition are listed below and can be ordered instead.
You're viewing
Linahenz M OD 1000mg/5mg Tablet ER
RxLa Renon Healthcare Pvt Ltd
₹183 Out of stock
View details Same composition & strength
2A like-for-like swap — identical active ingredients, same strength and form as Linahenz M OD 1000mg/5mg Tablet ER.
Same molecule — other strengths or forms
5Same active ingredient(s) but a different strength or form — check the strength matches your prescription.
About these molecules
Linagliptin5mg
Full details →Linagliptin is an oral medication used to manage type 2 diabetes mellitus. It belongs to the class of DPP-4 inhibitors, which work by increasing insulin secretion and decreasing glucagon levels in response to meals. This helps lower blood glucose levels effectively. Linagliptin is often prescribed alongside diet and exercise to improve glycemic control. Side effects may include upper respiratory infections and headache. In summary, Linagliptin is a valuable option for managing type 2 diabetes.
Metformin1000mg
Full details →Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
Why a generic substitute?
Same active ingredient
A substitute has the exact same salt(s) — so it works the same way as the brand.
Often much cheaper
Generics can cost a fraction of the branded price for the identical molecule.
Quality-regulated
All medicines we list are from licensed sellers and meet the same standards.
Substitutes share the same active ingredients, but always confirm the strength and form with your doctor or pharmacist before switching — especially for chronic, prescription or narrow-therapeutic-index medicines.
